Finance

Lists
014570:KOSDAQ
Korean Drug Co Ltd
â‚©3,415.00
0.00%
(0.00) 1D
Sep 21, 3:30:24 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 014570...
Open
â‚©3,415
High
â‚©3,425
Low
â‚©3,380
Mkt. cap
37.56B
Avg. vol.
5.18K
Volume
387.00
Dividend
5.27%
Quarterly dividend
â‚©45
Ex-dividend date
Dec 27, 2023
P/E ratio
24.91
52-wk high
â‚©4,645
52-wk low
â‚©3,060
EPS
â‚©137
Shares outstanding
11.00M
No. of employees
233
Open
â‚©3,415
High
â‚©3,425
Low
â‚©3,380
Mkt. cap
37.56B
Avg. vol.
5.18K
Volume
387.00
Dividend
5.27%
Quarterly dividend
â‚©45
Ex-dividend date
Dec 27, 2023
P/E ratio
24.91
52-wk high
â‚©4,645
52-wk low
â‚©3,060
EPS
â‚©137
Shares outstanding
11.00M
No. of employees
233
About Korean Drug Co Ltd
CEO-
Employees233
Founded1980
Headquarters-
SectorPharmaceutical industry
Website-
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
16.49B
18.00B
13.34B
17.57B
Cost of goods sold
9.56B
10.52B
7.18B
9.33B
Cost of revenue
9.56B
10.52B
7.18B
9.33B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.71B
5.36B
4.72B
5.40B
Operating expense
4.95B
5.59B
4.98B
5.58B
Total operating expenses
14.51B
16.11B
12.16B
14.91B
Operating income
1.98B
1.89B
1.18B
2.66B
Other non operating income
217.29M
141.47M
35.62M
47.51M
EBT including unusual items
2.31B
2.14B
1.46B
2.83B
EBT excluding unusual items
2.37B
2.20B
1.43B
2.89B
Income tax expense
405.85M
330.65M
259.40M
6.27B
Effective tax rate
17.54%
15.43%
17.76%
221.47%
Other operating expenses
152.56M
147.51M
115.08M
94.29M
Net income
1.91B
1.81B
1.20B
-3.44B
Net profit margin
11.58%
10.07%
9.01%
-19.59%
Earnings per share
-
-
-
-
Interest and investment income
161.56M
178.88M
200.37M
197.04M
Interest expense
-1.09M
-923.00K
-1.13M
-1.10M
Net interest expenses
160.47M
177.96M
199.24M
195.94M
Depreciation and amortization charges
80.10M
78.84M
79.46M
79.65M
EBITDA
2.48B
2.38B
1.66B
3.16B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps